For years, studies have suggested that drinking coffee could be linked to a longer life and a lower risk of chronic illnesses. Now, new research is shedding light on why.
Scientists at Texas A&M University College of Veterinary Medicine and Biomedical Sciences say compounds found in coffee may help protect the body by activating a key receptor tied to aging and disease.
Recommended Videos
The findings, recently published in Nutrients, offer one of the clearest biological explanations yet for coffee’s widely observed health benefits.
Researchers focused on a receptor in the body known as NR4A1 receptor, which plays a role in how the body responds to stress, inflammation, and damage.
“This receptor acts like a nutrient sensor,” said Dr. Stephen Safe, a professor involved in the study. “When tissues are damaged, it helps reduce that damage. Without it, the effects can be worse.”
The receptor is already known to be involved in processes tied to aging, including metabolism, inflammation, and tissue repair, all of which are linked to diseases like cancer and neurodegenerative conditions.
While coffee has long been associated with lower risks of diseases such as Alzheimer’s and Parkinson’s, most research has been observational, meaning scientists saw the effects but didn’t fully understand the cause.
In this study, researchers found that several compounds in coffee, especially polyphenols like caffeic acid, can bind to and activate the NR4A1 receptor.
That activation appears to:
- Reduce cellular damage
- Influence how cells respond to stress
- Slow the growth of cancer cells in lab models
When researchers removed the receptor, those protective effects disappeared, strengthening the case that NR4A1 plays a key role.
Despite coffee’s reputation, researchers say caffeine may not be the main factor behind these benefits.
Instead, naturally occurring plant compounds, also found in fruits and vegetables, appear to have a stronger impact on the receptor.
That could help explain why both regular and decaffeinated coffee have been linked to similar health outcomes.
Researchers caution that the study does not prove direct cause-and-effect in humans. Instead, it helps explain the biological mechanisms that may be at play.
“There are many pathways involved,” Safe said. “This is likely one important piece of a much bigger puzzle.”
The findings could eventually help scientists develop new treatments targeting the same receptor for conditions like cancer and metabolic disease.